Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 779

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for

Locally Advanced Cervical Adenocarcinoma,

Location: Buffalo NY, Erie PA, Seneca PA, Oswego NY, Syracuse NY,

Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,

Location: Buffalo NY, Hamilton, Toronto, Rochester NY, London,

Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for

Extensive Stage Lung Small Cell Carcinoma,

Location: Buffalo NY, Rochester NY, Webster NY,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase 2, Recruiting

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

for

Richter Syndrome, Diffuse Large B-Cell Lymphoma,

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06863402

Phase 2, Recruiting

Intratumoral N17350 in Advanced Solid Tumors

for

Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative,

Location: Buffalo NY, Houston TX

Sponsor: Onchilles Pharma Inc

Sex: All

Age: 18+

Code: NCT07339176

Phase 1, Phase 2, Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

for

Metastatic Ewing Sarcoma

Location: Buffalo NY, The Bronx NY, Columbus OH, Lexington KY,

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1+

Code: NCT07194044

Phase 1, Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

for

Lung Non-Small Cell Carcinoma

Location: Buffalo NY, Camillus NY, East Syracuse NY, Sylvania OH,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07388524

Phase 3, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,

Location: Buffalo NY, Lewisburg PA, Monroeville PA, Pittsburgh PA,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase 3, Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for

Advanced Solid Tumors

Location: Buffalo NY, Hackensack NJ, New York NY, Boston MA,

Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox Study)

for

Cigarette Smoking-Related Carcinoma, E-Cig Use

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18 - 25

Code: NCT07167225

Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Buffalo NY, Rochester NY, Syracuse NY, Danville PA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

for

Locally Advanced Colorectal Carcinoma,

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06307548

Phase 1, Phase 2, Recruiting

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

for

Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8,

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: Male

Age: 18+

Code: NCT06733350

Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for

Pancreatic Neoplasm

Location: Buffalo NY, Danville PA, East China MI, Wilkes-Barre PA,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Childhood Cancer Survivor Study

for

Cancer

Location: Buffalo NY, Toronto, Pittsburgh PA, Ann Arbor MI,

Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for

Acute Myeloid Leukemia

Location: Buffalo NY, Columbus OH, Grand Rapids MI, Chicago IL,

Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT06969430

Phase 1, Phase 2, Recruiting

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

for

Borderline Resectable Pancreatic Ductal Adenocarcinoma

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06821997

Phase 2, Recruiting

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

for

Smokeless Tobacco

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 21+

Code: NCT07107139

Recruiting

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

for

Breast Carcinoma

Location: Buffalo NY

Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06833255

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for

Recurrent Non-Muscle Invasive Bladder Carcinoma,

Location: Buffalo NY, Lewisburg PA, Danville PA, Dickson City PA,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

Paid Clinical Trials Buffalo

Filter results

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Intratumoral N17350 in Advanced Solid Tumors

Interested in new trials?

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox Study)

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Childhood Cancer Survivor Study

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy